Company intelligence / Profile preview

Emcutix Biopharmaceuticals

Pune, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

Emcutix offers category-defining commercial products in dermatology, including prescription, consumer, and aesthetic segments. Key launches like Ureaderm (urea-based moisturizers for psoriasis, ichthyosis, dry skin), PRX-PLUS (non-invasive skin tightening), and Flawlizo (acne care) are available across India, with evidence-based efficacy focused on skin barrier restoration and hydration[1][3][11].

Therapeutic areas: Dermatology
Modalities: Small moleculeBiologicMedical device (cosmeceutical/aesthetic)
Industry: Biotech

Drug pipeline

5 assets

Flawlizo

Unknown

4 more assets in the full pipeline.

Request access →

Partnerships

Mantra Pharma (Ureaderm launch, manufacturing/marketing)[1]WiQo (exclusive in-license for PRX-PLUS)[3][7][8]

Beyond the preview

Go deeper on Emcutix Biopharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emcutix Biopharmaceuticals.

Explore the full profile